title: Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
authors.affiliation: First Department of Surgery, Nara Medical University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Ueno
authors.forename: Y
authors.initials: Y
authors.lastname: Nakajima
authors.forename: M
authors.initials: M
authors.lastname: Segawa
authors.forename: M
authors.initials: M
authors.lastname: Hisanaga
authors.forename: H
authors.initials: H
authors.lastname: Yabuuchi
authors.forename: A
authors.initials: A
authors.lastname: Yoshimura
authors.forename: H
authors.initials: H
authors.lastname: Nakano
mesh_terms: D000818:Animals; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D051381:Rats; D011919:Rats, Inbred Strains; D013601:T-Lymphocytes / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use*; D013950:Thymus Gland / Q000187:drug effects / Q000473:pathology; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
chemical_list: D006146:Guanidines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; C037258:gusperimus; D016559:Tacrolimus